Match Document Document Title Score
6544968 Use of angiotensin II receptor antagonists for treating acute myocardial infarction  
The invention relates to the use of an angiotensin II receptor antagonist or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of acute MI and for...
45
US20040258668 Method for regulating the expression of genes carried on a viral vector  
The present inventors revealed that non-steroidal anti-inflammatory drugs and muscle relaxants suppressed the expression of genes carried on viral vectors. These agents also suppressed viral...
45
US20140343021 ADJUVANT TO THROMBOLYTIC THERAPY FOR THE TREATMENT OF FROSTBITE  
A method of treating frostbite in a subject using a water-soluble cocrystal composition which contains a quantity of acetylsalicylic acid and a quantity of a theanine enantiomer.
45
US20140288029 INTRAVENOUS FORMULATION WITH WATER-SOLUBLE COCRYSTALS OF ACETYLSALICYLIC ACID AND THEANINE  
A method of treating myocardial infarction in a subject using a water-soluble cocrystal composition which contains a quantity of acetylsalicylic acid and a quantity of a theanine enantiomer.
45
9289440 Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine  
A method of treating myocardial infarction in a subject using a water-soluble cocrystal composition which contains a quantity of acetylsalicylic acid and a quantity of a theanine enantiomer.
45
US20130012482 INTRAVENOUS FORMULATION WITH WATER-SOLUBLE COCRYSTALS OF ACETYLSALICYLIC ACID AND THEANINE  
A water-soluble cocrystal composition contains a quantity of acetylsalicylic acid and a quantity of a theanine enantiomer selected from an alpha variant of theanine or a beta variant of theanine...
45
US20090123567 BISBENZISOSELENAZOLONYL DERIVATIVES HAVING ANTINEOPLASTIC, ANTI-INFLAMMATORY AND ANTITHROMBOTIC ACTIVITIES AS WELL AS THEIR USE  
The present invention relates to new bisbenzisoselenazolonyl derivatives of the following general formula (I), wherein R is C4-5-alkylene, and their pharmaceutically acceptable salts. The...
44
5916906 Compositions comprising nicotinylalanine and an inhibitor of glycine conjugation or vitamin B6  
This invention relates to compositions comprising nicotinylalanine (NAL) and/or related analogues, and an inhibitor of glycine conjugation, either synthetic or naturally occurring. Vitamin B6 may...
44
8563776 L-Threonine derivatives of high therapeutic index  
The present invention is directed to a derivative comprised of an L-Threonine bonded to a medicament or drug having a hydroxy, amino, carboxy or acylating derivative thereon. The derivative has...
44
5063220 Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl )piperazine  
A pharmaceutical formulation suitable for parenteral (preferably intravenous) administration includes an effective amount of...
44
US20090155398 JUCARA AND ACAI FRUIT-BASED DIETARY SUPPLEMENTS  
The present invention relates to stable, palatable, freeze-dried, fruit-based dietary supplements. Specifically, the inventions relates to compositions of Açai fruit and Jucara fruit with high...
44
US20160106781 HIGH TELOMERASE ACTIVITY BONE MARROW MESENCHYMAL STEM CELLS, METHODS OF PRODUCING THE SAME AND PHARMACEUTICALS AND TREATMENT METHODS BASED THEREON  
Disclosed are isolated human bone marrow mesenchymal stem cells having high telomerase activity (tBMMSCs). Also disclosed are isolated human CD34+ bone marrow mesenchymal stem cells. Also...
44
3927213 Prostaglandin E2 and derivatives for reducing the side effects of anti-inflammatory agents  
A method is disclosed for inhibiting and alleviating gastrointestinal side effects often encountered during therapy with antiinflammatory agents such as indomethacin, phenylbutazone,...
44
US20040147606 Medicinal compositions  
Medicinal compositions characterized by containing fudosteine and an antipyretic/analgesic. These medicinal compositions are medicinal compositions to be used for common cold, etc. which have...
44
9585899 Method of inhibiting platelet aggregation and clot formation  
The instant invention provides methods and compositions for the treatment, prevention and diagnosis of for example, platelet aggregation or clot formation in a subject. The invention inhibits the...
44
US20050036952 Compositions and methods for the treatment of aches and pains  
Provided are methods and compositions useful for treating aches and/or pains. The compositions comprise an aqueous medium having dispersed or dissolved therein an herbal therapeutic agent and/or...
44
US20190167693 METHOD OF TREATING PATIENTS COADMINISTERED A FACTOR Xa INHIBITOR AND VERAPAMIL  
The present disclosure in various embodiments teaches methods of treating patients in need of treatment with a Factor Xa inhibitor, and who are also concomitantly administered verapamil.
44
US20170073650 RECOMBINANT THERAPEUTIC GLYCINE N-ACYLTRANSFERASE  
This invention relates to a method of producing a recombinant enzyme, more particularly, this invention relates to a method of producing water soluble enzymatically active recombinant glycine...
44
10125353 Recombinant therapeutic glycine N-acyltransferase  
This invention relates to a method of producing a recombinant enzyme, more particularly, this invention relates to a method of producing water soluble enzymatically active recombinant glycine...
44
5164379 Sucralfate/cyclodextrin complexes  
Complexes of sucralfate with alpha cyclodextrin, beta cyclodextrin, gamma cyclodextrin or 2-hydroxypropyl beta cyclodextrin are disclosed. Also disclosed are a process for producing complexes and...
44
US20090118243 Compositions and methods for the treatment of ophthalmic conditions  
The invention relates to methods of treating ophthalmic conditions comprising administering a compound of formula A, a compound of any one of formulae 1-49, a lipoxin compound, or an oxylipin...
44
US20040132780 Method and compositions for treating migraines  
The present invention relates to a method for treating or preventing migraines in a mammalian patient in need of such treatment or prevention comprising administering to said patient a compound of...
44
US20090137527 Compositions and methods for modulating immune function  
The invention relates to methods of modulating immune function, suppressing immune response, treating autoimmune diseases or autoimmune disorders, and treating diseases, sequelae or pathological...
44
5455229 Method for minimizing and containing ischemic and reperfusion injury  
The present invention is a method for minimizing and containing injury caused when tissue is subject to ischemia and reperfusion. The method comprises administering certain derivatized tripeptide...
43
US20080292730 NUTRITIONAL SUPPLEMENT FOR OSTEOARTHRITIS  
The present invention relates to a method of treating osteoarthritis by administering a mineral composition in the form of a nutritional supplement, where the mineral composition may contain...
43
US20100261686 Pharmaceutical combination for the treatment of pain (acute or chronic), as powerful as a narcotic medication but non narcotic ,therefore very unlikely to create addiction  
The management of pain specially chronic pain often requires the use of opiate like medications which have a large number of undesirable effects, the most important one being habituation and...
43
7611732 Nutritional supplement for osteoarthritis  
The present invention relates to a method of treating osteoarthritis by administering a mineral composition in the form of a nutritional supplement, where the mineral composition may contain...
43
5051406 Pharmaceutical composition using albumin as a carrier and process for producing the same  
The pharmaceutical composition of the present invention is a pharmaceutical composition of high drug content containing 1-200 parts by weight of a drug having a protein binding property and 100...
43
9789187 Stable pharmaceutical composition for atherosclerosis  
The present invention relates to a stable solid oral pharmaceutical multi-component composition comprising combination of blood pressure lowering drugs with lipid lowering agent/s and optionally a...
43
7419657 Treatment of atherosclerotic disorders  
The present invention relates to the identification of lipid oxidizing abzymes as a key pathogenic factor in atherosclerotic disorders. Methods and means for the reduction of abzyme mediated lipid...
43
US20140037727 Tablet Of Paracetamol Containing An Encapsulated Flavorant  
A medicament tablet containing paracetamol (acetaminophen) as the (or an) active ingredient, and an encapsulated flavorant. The tablet may be swallowed in tablet form or may be dissolved or...
43
US20100130453 USE OF FOLATES FOR THE PREVENTION AND TREATMENT OF VASCULAR DISEASES  
This invention relates to the use of folates for the prevention and/or treatment of cardiovascular diseases, such as atherosclerosis, and in particular for modulating endothelial nitric oxide...
43
US20060034913 Multiplex drug delivery device  
A capsule or shell for oral administration at the onset of an acute adverse health event (e.g. chest pain). The shell has a plurality of impermeable enclosures in which dosage units are situated....
42
US20090004290 RED YEAST RICE COMPOUND FOR CANCER CHEMOPREVENTION  
The invention concerns a composition containing red yeast rice and other components, as a chemopreventative agent to reduce the risk of cancer.
42
7090858 Coated filter bag material for oral administration of medicament in liquid and methods of making same  
A coated filter bag for use in cold or hot drinks, in particular, a novel method for administration of pharmaceutical actives, supplemental nutrients, genetically derived materials, or other...
42
US20100182600 SELF-CONTAINED MULTIVARIATE OPTICAL COMPUTING AND ANALYSIS SYSTEMS  
An optical analysis system includes a light source configured to radiate a first light along a first ray path; a modulator disposed in the first ray path, the modulator configured to modulate the...
42
7585850 Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases  
The invention is directed to compositions and methods which permit the oral use of adenosine and adenosine phosphates for cardiovascular applications such as pulmonary artery hypertension, cardiac...
42
US20070254856 Use of acetylsalicylic acid (ASA) in the application of a membrane lung  
Acetylsalicylic acid (ASA) is used as a medicament which is administered to a human patient in connection with a treatment of the patient with a membrane lung, in order to avoid or reduce a...
42
US20180344680 COMPOSITIONS AND METHODS FOR TREATMENT, AMELIORATION, AND PREVENTION OF DIABETES-RELATED SKIN ULCERS  
Compositions and methods are provided for treating, ameliorating, and preventing diabetes-related skin ulcers in a mammalian subject comprising administering to the subject an effective amount of...
42
4316884 Sustained release pharmaceutical formulation  
It has been found that indoprofen can be used in increased safety at its effective anti-inflammatory dose in humans and that the activity of indoprofen is greatly prolonged by microencapsulating...
42
US20080089950 Methods and compositions for modulating the immune system and uses thereof  
The present invention provides methods of preventing, treating or ameliorating one or more symptoms of disorders in which modulation of a subject's immune system is beneficial utilizing a lymphoid...
42
8895061 Compositions comprising carisoprodol and methods of use thereof  
The present invention provides compositions comprising carisoprodol or pharmaceutically acceptable salts, esters or derivatives thereof. In certain embodiments, the invention provides...
42
US20100189782 Compositions Comprising Carisoprodol and Methods of Use Thereof  
The present invention provides compositions comprising carisoprodol or pharmaceutically acceptable salts, esters or derivatives thereof. In certain embodiments, the invention provides...
42
7175852 Implant and process for producing it  
The invention relates to a process for producing an implant, with the implant possessing a textured foreign structure. A porous protein matrix is at least partially anchored in the textured...
42
US20170326119 NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITOR  
The present invention provides for salts comprising a compound of Formula I and an acid that has activity against mammalian factor Xa. The present invention is also directed to methods of making...
42
4752606 Pharmaceutical compositions and preparations thereof  
The invention provides oleanolic acid and/or a physiologically acceptable salt thereof for use in treating a patient prophylactically and/or therapeutically for ulcerogenic-type disorders of the...
42
9452180 NSAIDs-induced gastrointestinal mucosal disorder alleviator and manufacturing method thereof  
A method of manufacturing a medical drug of alleviating damage of gastrointestinal mucosal induced by a non-steroidal anti-inflammatory drug, NSAID, the medical drug being able to induce...
41
US20050049229 Therapeutic applications of 2-hydroxyacetanilide  
2-Hydroxyacetanilide may be formulated for use in medicine as a therapeutic or prophylactic agent for application as an anti-inflammatory and/or an anti-platelet aggregation drug.
41
US20160256383 COMPOSITIONS AND METHODS FOR COMBINATION INGREDIENT DELIVERY  
Described herein are compositions, methods, and devices for relief of a cough, cold, sore throat, or allergy, or a related symptom. Also described herein are compositions, methods, and devices for...
41
9061019 Pharmaceutical salts and polymorphs of a factor Xa inhibitor  
The present invention provides for salts comprising a compound of Formula I and an acid that has activity against mammalian factor Xa. The present invention is also directed to methods of making...
41


Search
« search again